✦ LIBER ✦
Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia
✍ Scribed by S. Grammatico; L. Elia; A.L. Peluso; L. Pedace; M. Matarazzo; A. Vitale; A. Rago; F. Pane; R. Foà; G. Cimino
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 275 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.